Professional Documents
Culture Documents
CP Nanos Bilan Perspective English
CP Nanos Bilan Perspective English
CP Nanos Bilan Perspective English
N A N O M A T
E R I A L S
C O N T E N T S
04 05
N anomaterials :
a p riorit y
f or p re v ention
occupational health issues of nanoparticles in an expert
opinion published in 2007 [4]. It was found that there
was a considerable need for research and an urgent
need to develop prevention measures appropriate for
The development of manufactured nanomaterials various estimates, some 300,000 to 400,000 people are nanoparticles.
entails exposure of increasing numbers of workers. currently employed in the nanotechnologies in Europe.
Since the early 2000s, even though concerns have been In France, over 5,000 workers in companies and 7,000 In 2008, INRS set up an action programme for
expressed about the health effects of nanomaterials, laboratory researchers might be exposed. nanomaterial-related risks. This is currently continuing
huge budgets have been devoted to research into new as part of its 2013-2017 strategic plan, and is organised
applications all over the world. Nanomaterials have a Anticipating and controlling nanomaterial-related risks around three goals designed to provide some answers
growing impact not only in cutting-edge sectors such are among the priorities of most occupational health and to the challenges raised by nanomaterials.
as electronics, aeronautics and alternative energies, safety organisations. In the US, NIOSH is undertaking
but also in traditional sectors such as the chemical, a considerable research effort in this field. INRS has The programme builds both on INRS's multidisciplinary
ials
A new Nanomaatet rINRS
plastics, automotive, building, food and cosmetics been working hard for several years to provide solutions teams, which bring together toxicologists, chemists,
industries. However, most funding is oriented towards and make them available to those in charge of risk physicists, air flow experts, physicians and
epidemiologists, and on external partnerships. Much of
Research Unit
the development of applications, while very little goes prevention in the workplace. In this respect, INRS was
to occupational health and safety issues. According to one of the first organisations to turn the spotlight on the the work is carried out within the context of doctoral
theses and cooperation, both nationally (CARSAT/CRAM,
ately 600 m ,
2
ANSES, CNRS, Universities, engineering schools, IRSN, pr ox im
, with an ar ea of ap
InVS, INERIS, CEA, etc) and internationally (European
This new laboratory arch into
projects, PEROSH network, OECD, the European Agency toge th er a ra ng e of means for rese
brings :
for Safety and Health at Work in Bilbao, ISSA, etc). The ed risks. It includes
nanomaterial-relat
Objectives of the INRS Nano programme primary aim of this work is to enhance knowledge
ed fo r to xi cology studies, na
noparticle
(laboratory research and field studies) and transfer it to the
a n area re se rv s) by inhalation,
workplace (assistance, information and training). an d ex po su re of animals (rodent
generatio n sting;
gu la to ry re qu ire ments for animal te
ective meeting the re k on
Experimental to
xicology of exposed Studies of collprotection
The programme includes the acquisition of new
ly dedicated to wor
Identification so n al equipment and the setting up of safe testing facilities: n ISO class 5 cl ea n ro om in itial
populations and per a
n equipment;
Epidemiology ides,
measures, Gu aining
recently, INRS has set up a new laboratory that brings
collective protectio
Metrology cility
Knowledge tran
sfer
informatio n, tr together research activities relating to the toxicity,
ar ea fo r th e CA IM AN experimental fa
udies azone includin
g an ts and controlled
Workstation st
metrology and characterisation of nanomaterials and to
ui pp ed with safety cabine
the efficiency of protective equipment.
and four ar ea s eq nanoparticle
am be rs , fo r ac tivities relating to
environment ch tive
e d respiratory protec
NAN 1 objectiv In April 2011, the scientific conference on nanoparticle- an d m et ro lo gy , an
and nanomaterial-related risks organized by INRS in characterisation
laces
Provide workp e e devices.
NAN 2 objectiv
Nancy in partnership with the PEROSH network was
out inhalation
with knowledgctured e attended by over 450 people, enabling them to share un it re sp on ds to the need to carry
d human
NAN 3 objectiv This resear ch
about manufa related Provide OSH with state-of-the-art knowledge and discuss research needs in
le s fa ci lit ie s, m ea suring equipment an
fferent
nanomaterial- professionals fy, ention
Propose prevnd
the field [10]. Over the past decade much effort has gone studies. It enab
ed , an d fo st er s sy nergies between di
hazards. tools to identi nd resources to be pool out and equipped ac
cording to INRS
approaches aanies
into developing standards, guides of good practice and
la id
characterise apational re manufactu-
. It ha s be en
methodologies for risk assessment and control. Although disciplines in laboratories whe
tools to comp es en tio n
measure occu ns fo r pr ev
progress has been achieved, many questions remain. recommendatio
and laboratori ctured are handled (ED 6115
).
exposures to where manufa are red nanomaterials
manufactured . nanomaterialsandled.
This document aims to present nanomaterial-related
nanomaterials produced or h
occupational health issues as well as the resources
deployed by INRS to find solutions, share them and
disseminate them to various target audiences.
06 07
Nanomaterials
W h at are
nanomaterials ? Nanoparticles (powders, Materials containing Materials structured
liquid suspensions, aerosols) nanoparticles on the nanometre scale
to monodisperse). That is why some definitions also propose can be distinguished by their chemical properties. Various volume. One of the important characteristics of nanomaterials
is the magnitude of their specific surface area per unit volume.
a threshold for the numerical size distribution of the primary processes such as coating or functionalisation of particles The smaller the size, the greater the surface area/volume ratio.
particles: beyond this threshold, the material is considered to by polymers or other molecules can alter their properties, For instance, a specific surface area of 60 m2/cm3 corresponds
be a nanomaterial (the values proposed for this threshold lie giving rise to increasingly sophisticated materials (active to a monodisperse population of particles smaller than 100 nm.
Multi-walled carbon nanotubes seen through between 0.15 and 50% in number). From a practical point of nanostructures able to respond to external stimuli, known as
a transmission electron microscope. 2
An aggregate is a cluster of particles held together by strong
view, measuring the size and size distribution of the primary 'second-generation nanomaterials'). All these processes lead chemical bonds (covalent bonds).
particles requires the use of sophisticated techniques, and there to a new material whose properties are fundamentally different
is as yet no standardised method. It should be stressed that
3
An agglomerate is a cluster of particles either held together
from those of the original material.
by weak physical bonds (such as van der Waals forces) or
these definitions are based on a categorisation of particles by
entangled (this is the case for nanotubes for instance). An
size and do not include any aspects related to their chemical This document deals with nano-objects, their agglomerates agglomerate can be broken up by a low energy source (shaking,
properties or their hazards. and aggregates (NOAAs) intentionally produced industrially ultrasound).
08 09
W h ere are
nanomaterials f o u n d ?
W h at are t h e h ealt h
e f f e c ts o f nanomaterials ? and lymphatic system, and attain various organs such as the
spleen, liver, heart, central nervous system and bones. When some
nanomaterials such as manganese oxide and titanium dioxide are
deposited in the nose they may migrate and accumulate in certain
One of the prerequisites in nanotoxicology is therefore the parts of the brain after crossing the blood-brain barrier.
physicochemical characterisation of materials to be tested, not
only before exposure but also in the exposure environment. For particles of identical chemical composition and shape,
Nanoparticles have specific surface properties (electric charge, reducing their size causes (at equal mass) an increase in their
porosity, crystal structure, etc) that govern their interaction with specific surface area and in the number of reactive groups likely
the environment in which they are present. This can allow them to interact with biological media. Several studies have shown that
to adsorb onto their surface macromolecules found in biological titanium dioxide, a substance supposed as having low toxicity, has
The health effects of ultrafine particles caused by air media, building a protein or lipidic corona that can affect the a far greater inflammatory effect on the lungs at the nanometre
pollution or welding processes have long been studied. distribution and behaviour of the particles in the body. Recent scale than at the micrometre scale, for a dose of equivalent mass
Epidemiological studies and human trials under controlled research in this field shows that, in addition to the intrinsic and identical crystal form. In these studies, the dose expressed as
exposure conditions suggest in particular the possibility of characteristics of nanomaterials, it is also necessary to take into surface area was better correlated with the observed effects than
respiratory and cardiovascular effects. Although epidemiological account their biological environment, which adds an extra layer the dose expressed as mass.
studies have been carried out on workers exposed to carbon of complexity. Lastly, surface alterations, especially by coating of
black or titanium dioxide, it is difficult to draw any conclusions particles or functionalisation, can modulate these interactions. Some nanoparticles, especially metal oxides, can produce
from this work since the size of the dust particles is never clearly reactive oxygen species (ROS, also known as free radicals)
established. Consequently, today there exist practically no studies Penetration into the body on their surfaces or cause them to be produced by cells.
on the specific effects of manufactured nanomaterials on humans. In the workplace, inhalation and skin contact are the main possible This situation can result in toxic phenomena. Induction
There are several obstacles to carrying out such studies, such contamination routes. The penetration of insoluble nanomaterials of oxidative stress is certainly a critical parameter for the
as inadequate information about exposure, lack of knowledge of through the skin has been the subject of a few studies. determination of nanoparticle toxicity: the connection between
early effects to be measured, and restricted access to companies. Percutaneous penetration seems unlikely, and only appears to be the ability of nanoparticles to produce oxidising species in vitro
In France, the EpiNano monitoring system for workers potentially significant if the skin's stratum corneum is damaged. Inhalation and the onset of inflammatory effects in vivo has been clearly
exposed to nanomaterials set up by InVS could serve as a basis is the predominant penetration route into the body. There are demonstrated for various nanoparticles.
for future epidemiological studies. a number of validated theoretical models that can be used to
estimate the likelihood of deposition of inhaled particles according As well as their chemical composition, the shape of nano-objects
Although the experimental toxicity of nanomaterials has been to their size. Particles with a diameter between 10 and 100 nm are is a determining factor in their biological activity. Several in vivo
the subject of much research, the findings are often of limited mostly deposited in the pulmonary alveoli, in a significantly higher studies have compared the effects of fibrous and spherical
significance: in vitro studies on cellular models that are difficult to proportion than for micrometre-scale particles. Smaller particles titanium dioxide and carbon nanoparticles, and concluded that, at
extrapolate to humans, in vivo studies on animals using exposure are mainly deposited in the upper airway and, to a lesser extent, equivalent doses, the fibrous form causes greater inflammatory
routes that are not representative of occupational exposure, short in the tracheobronchial region. effects. The extremely large length-to-diameter ratio of carbon
exposure periods, insufficient physicochemical characterisation nanotubes, combined with their biopersistence, has raised
and a wide variety of tested materials. Such studies rarely involve Fate in the body and biological activity concern about their ability to trigger pulmonary reactions similar
inhalation even though this is the exposure route of most concern Particle size not only determines the site of deposition but also to those caused by asbestos.
for workers. the efficiency of pulmonary clearance4 systems. In the pulmonary
alveoli, clearing cells called macrophages usually take care of Lastly, just as for micrometre-scale particles, the solubility of
The goals of nanotoxicology are, on the one hand, to study the the elimination of insoluble contaminants via a phagocytosis nanoparticles can have an impact on biological effects. Slow
ability of nanoparticles to penetrate the body, their fate in the mechanism5. However, the phagacytosis capacity of these dissolution with release of hazardous compounds such as toxic
body and how they are eliminated, and on the other, to identify macrophages is weaker with regard to nanoparticles than to larger ions can become a major factor of toxicity: then the solubilised
their effects both at the site of deposition and at a distance from particles. This may result in a significant accumulation of nano- nano-objects are transferred from the lungs to the bloodstream.
it. It is also important to determine the dose-response relationship objects in the pulmonary alveoli as well as greater interaction with
as well as the kinetics of biological responses. This is a complex the alveolar cells. This overload is likely to cause inflammation
task due to the diverse physico-chemical characteristics of that may eventually lead to the development of lung diseases.
nanomaterials, which affect their behaviour at the molecular, cell 4
Pulmonary clearance: a measurement of the ability of the lungs
and organic level. The size and distribution of nanoparticles, the It has been shown that in certain cases nanoparticles are able to to eliminate a substance (amount of substance eliminated per
extent of agglomeration and aggregation, their ability to produce cross tissue barriers that are considered to have low permeability. unit time).
Microscopy observation of a cell culture being treated oxidants, and their shape, surface characteristics and solubility all Once inhaled, they can cross the alveolar wall, migrate to the A mechanism that enables certain specialised cells (macro-
5
with nanoparticles. play a key role in determining their toxicity. pleura and to the lymph node structures, reach the bloodstream phages, neutrophil granulocytes) to ingest foreign particles.
12 13
Aerosol metrology
Many recently available measuring instruments can be used Characterisation of Nanoparticle Aerosol Measuring
7
I s t h ere an y e f f e c ti v e
p rote c ti v e e q u i p ment
against nanomaterials ?
to inhalation. Understanding such changes is crucial if we wish to chamber15, must be applied as strictly as possible when it ventilation of their operating space. Some are now specifically
determine worker exposure and design air cleaning systems. comes to protection from nanoaerosols. designed for nanomaterials.
22 23
Filtration of nanoparticles
Protective facilities against aerosols usually make use of
filters. This is the case for general ventilation systems,
ventilated chambers, and source capture systems, which
filter the air before discharge outside the workplace, and for
Other questions related to filtration remain to be adressed:
Respiratory protective equipment (RPE)
respiratory protective equipment, which purifies the ambient Penetration of nanoparticles into filtering RPE can occur
air before inhalation. Since 2005, INRS has been working via two routes: penetration through the filtering medium
Effect of nanoparticle morphology on filtration
on the measurement of nanoparticle filtration efficiency, in or penetration by leakage, especially at the head/facepiece
efficiency. US researchers have shown that filters are more
collaboration with the LRPG laboratory. It has been shown interface. Penetration of nanoparticles by leakage has been
effective when particles have an elongated morphology
that fibrous filters are an effective barrier to particles with a studied very little. Research at INRS has shown that significant
(nanofibres, nanotubes).
diameter exceeding 1 nm. Below this size, detection limits are consequences are to be expected in the event of leakage, and
reached [6, 35]. Thermal rebound17, which may be a reason Filter clogging since it can lead to a deterioration of the that the effect of a leak is all the greater if the filter equipping
for reduced filter efficiency, should only occur below this ventilation system. Actually, the greater the specific area the facepiece initially had high filtration efficiency [34]. Studies
threshold. In the specific case of electrically charged filters, a of the particles, the more the clogging ability of the layer of have therefore been carried out to measure the filtration
dramatic increase in filtration efficiency was observed. particles retained in the filter increases. efficiency of RPE with regard to nanomaterials, concerning The efficiency of respiratory protective equipment (seen here, air line breathing
both filtration and leakage impact. The work initially focused apparatus) is tested with regard to particles. The mask is placed on a standardised
on two types of commonly used masks (filtering half masks). head, put inside a chamber. A breathing machine is used to simulate human
It was carried out in collaboration with LRGP and IRSN on an
breathing. The aerosol is generated inside the chamber, and the concentrations
outside and inside the mask are monitored according to particle size.
experimental facility that attempted to reproduce as closely as
possible real operating conditions by using an artificial head
connected to a breathing machine [14, 36]. The results showed
that for this type of RPE the protective factor varies very little
with particle size. No deterioration in respiratory protection
was observed. This work made it possible to develop a
methodology for the determination of protective factors with
regard to nanoparticles. However, many other issues remain to
be explored.
W h at ris k
management Some of INRS's counterpart organisations such as NIOSH
There is still insufficient toxicological data about nanomaterials and exposures (control banding). Such methods have not toxicity, and whose only effect, if the dose is great enough,
to determine dose-response relationships, which therefore been validated and their effectiveness in companies remains is that of pulmonary overload. In France, these values, namely
restricts the definition of occupational exposure limits. Threshold uncertain. Given that it is necessary to make assumptions 10 mg/m3 (inhalable fraction) and 5 mg/m3 (respirable fraction)
limit values defined for dust reputed to have no specific effect19, in order to apply them, it is essential that the user has in- were laid down in 1984 (article R-4222-10 of the French
which is sometimes described as inert, are not applicable to depth expertise in the field of chemical risk prevention and Labour code). They correspond to dust levels now considered
nanomaterials that have a specific toxicity. nanomaterials. excessive by occupational health and safety experts.
26 27
These recommendations will be regularly revised as
Traceability of exposures
n
INRS's contributio
and when increasingly reliable information is published
about nanomaterial hazards and exposure levels. and medical surveillance
New information products will be made available to OSH
professionals, occupational health services, workers and
of workers to expert work
ials to
employers.
nt rib ut es its ex pe rtise on nanomater
ng
The prevention approach recommended by INRS will be
INRS receives many enquiries from occupational INRS co
rt co m m itt ee s an d specialised worki :
health services. Should workers potentially exposed to several expe na l an d international bodies
laid down in a guide for workplace intervention intended ith na tio
nanomaterials be subject to specific medical surveillance? groups working w
for OSH professionals and in a guide for waste disposal. group
Because of the gaps in our knowledge about the health ot ec hn ol og ie s- Na nomaterials' expert
The 'Nan nd a dozen
brings together arou
Other points concerning risk management currently
effects of nanomaterials, there is at present no consensus
under discussion will form the basis of further tools led by INRS, which CNAMTS, and
about the content and methods of medical surveillance [9].
en ta tiv es fr om CA RSATs/CRAMs and rent
and formalise a cohe
intended for companies, especially small enterprises. repres
Determining levels of inflammatory markers or of pro- n go al is to dr aw up is
ork. Discussion in th
INRS proposes and disseminates various information These will include guidelines for drawing up material whose mai
safety data sheets, development of an approach aimed at inflammatory proteins in biological media (blood, urine, e 'P re ve nt io n' ne tw
products about nanomaterials in order to assist action plan for th RSAT/CRAM
companies and laboratories in their prevention classifying nanomaterials on the basis of their physico- breath) is one avenue of research, although this is not
s le d to th e ap po intment by each CA
group ha implementing
approach (see page 27), and recommendations chemical properties and of the resulting potential hazards, yet at a stage that allows it to be proposed as a routine officer in charge of
of a nanomaterials technical and
regarding medical surveillance [9]. These tools were and integrating risk prevention through process design (new method. Medical surveillance must therefore be adapted
in th e fie ld . IN RS also contributes its
developed on the basis of state-of-the-art research carried production methods aimed at reducing nanomaterial toxicity, on a case-by-case basis, and its main objectives should be actio n
the CTNs.
out at INRS or published by other organisations in France improved monitoring of the evolution of materials throughout
to determine workers' aptitude for the job and inform them scientific support to
their life cycle, limiting exposure, etc). s part in
and in other countries. They are available on the INRS
about risks and protective measures. Keeping a record di ng st an da rd isation, INRS take
website and are aimed at a wide audience (from workers to Reg ar
45 7 'Nanotechnologie
s-
and ensuring traceability of all the information collected of th e AF NO R X ities
OSH professionals specialised in chemical hazards). Some the work on an d follows the activ
concerning health events, results of additional tests and ls ' co m m is si
of them were drawn up in close collaboration with national Nanomateria 229 and CEN TC 35
2
partners such as CARSATs/CRAMs and CNRS. exposures is of fundamental importance. This information t in th e IS O TC
INRS information products should be kept so that it can be made use of at a later date,
carrie d
commission
ou
s. It is al so pr es ent in the CEN/TC13
7
rt in
m ission and took pa
(available at www.inrs.fr) especially for epidemiological investigations.
'Workplace Atm os
st
ph er
no
es
rm
' co m
ative document on
exposure
drawing up th e fir
07).
D ISO/Tr 27628, 20
Nanomatériaux. Filtration de l’air et protection des
to nanomaterials (F
SES
salariés, ED 138 (2011).
ec ia lis ts re gu la rly participate in AN ials.
INRS sp nanomater
Nanomaterials: definitions, toxicological risk, working groups on
assessments and
t
characterisation of occupational exposure and rt in the permanen
Two experts take pa th' working group.
prevention measures, ED 6050 (2012). d Heal
'Nanomaterials an
ent' and
Nanomatériaux. Prévention des risques dans les
ke s pa rt in the 'Risk Assessm
INR S ta gation'
laboratoires, ED 6115 (2012).
e M ea su re m en t and Exposure Miti
'Exposur red
Les nanomatériaux : risques pour la santé et mesures e OE CD 's pr og ra mme on manufactu
groups in th workers
de prévention, ED 6064 (2012).
m at er ia ls , an d in the ICOH 'Health of
nano .
aterials' committee
In addition, INRS regularly takes part in awareness- Dioxyde de titane - Fiche toxicologique, No 291 (2013).
exposed to nanom
raising and information days (organised for instance rts on
Aide au repérage et à la prise en compte du risque nano
ha s co nt rib ut ed to several repo tional
by regional occupational health services or as part of
en entreprises, to be published in 2013. INR S
pi c Centre for Occupa ty
er ia ls fo r th e To
conferences on prevention). Since 2009 it has offered three- nanomat ency for Safe
at the European Ag
day training courses aimed at a wide variety of audiences, Nanomatériaux. Assainissement de l’air des locaux de
Health and Safety
including researchers, engineers, OSH professionals and k in Bilbao.
industrial medical officers concerned by activities involving
travail, Fiche pratique, to be published in 2014. and Health at Wor
p at the
nanomaterials. By the end of 2013, around 140 people will Dioxyde de titane - Guide technique,
INR S pa rt ic ip at es in an expert grou ogies (OMNT).
have attended the courses. to be published in 2014.
rv at oi re de s M ic ro et Nano-Technol
Weighing a sample of nanopowder under safe Obse
conditions, using a special ventilated chamber.
28 29
[28] B au S., Witschger O., Gensdarmes F., Thomas D.
'Evaluating three direct-reading instruments
based on diffusion charging to measure surface
[18] Gaté L. et al area concentrations in polydisperse nanoaerosols
'Pulmonary toxicity of iron oxide nano- and sub- in molecular and transition regimes', Journal of
an d te c h ni c al [19] Gaté L. et al
[29] B au S., Witschger O.
'A modular tool for analyzing cascade impactors
T a b le
o f a b b re v iations
[ISPED]
Institut de santé publique, d’épidémiologie
et de développement, Université de Bordeaux
[ISSA]
[ANSES] International Social Security Association
Agence nationale de sécurité sanitaire de
l’alimentation, de l’environnement et du travail [LEMTA]
Laboratoire d’énergétique et de mécanique
[CARSAT/CRAM] théorique et appliquée, Université de Lorraine & CNRS
Caisse d’assurance retraite et de la santé au travail /
Caisse régionale d’assurance maladie [LRGP]
Laboratoire réactions et génie des procédés,
[CEA] Université de Lorraine & CNRS
Commissariat à l’énergie atomique
[NIOSH]
[CNRS] National Institute for Occupational Safety and Health,
Centre national de la recherche scientifique United States
[CTN] [NRCWE]
Comités techniques nationaux Nationale Forskningscenter for Arbejdsmiljø, Denmark
[ICOH] [OECD]
International Commission on Occupational Health Organisation for Economic Co-operation and Development
[IFA] [PACTE]
Institut für Arbeitsschutz der Deutschen Gesetzlichen Laboratoire Politiques publiques, Action politique, Collective publication by the Institut National
Unfallversicherung, Germany Territoires, Université de Grenoble & CNRS de Recherche et de Sécurité pour la prévention
des accidents du travail et des maladies
[INERIS] [PEROSH] professionnelles, coordinated by Martine
Institut national de l’environnement industriel Partnership for European Research in Occupational Reynier (INRS Scientific Management)
et des risques Safety and Health (www.perosh.eu)
Photographs by Jean-Pierre DALENS / INRS,
[InVS] [PHE] Gaël KERBAOL / INRS, Pollutants Metrology Division, INRS
Institut de veille sanitaire Public Health England, UK September 2013
[IRSN] [R&D]
Institut de recherche en sécurité nucléaire Research and development
[ISO] [SME]
International Organisation for Standardisation Small and medium-sized enterprise
Head office
65, boulevard Richard Lenoir, 75011 Paris
Tel.: +33(0)1 40 44 30 00 - Fax: +33(0)1 40 44 30 99
Lorraine centre
1, rue du Morvan - 54519 Vandœuvre-lès-Nancy cedex
Tel.: +33(0)3 83 50 20 00 - Fax: +33(0)3 83 50 20 97
www.inrs.fr
e-mail : info@inrs.fr
O u r j o b : m a k i n g yo u r s s a f e r